Prudential Financial Inc I Bio, Inc. Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $2,809 - $5,618	-12,215 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.55 - $1.04 $676 - $1,279	-1,230 Reduced 9.15%	12,215 $7,000
Q3 2021 Nov 15, 2021	BUY	$1.06 - $1.52 $1,028 - $1,474	970 Added 7.78%	13,445 $14,000
Q2 2021 Aug 16, 2021	SELL	$1.22 - $1.65 $927 - $1,254	-760 Reduced 5.74%	12,475 $19,000
Q1 2021 May 12, 2021	BUY	$1.18 - $2.62 $2,312 - $5,135	1,960 Added 17.38%	13,235 $20,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.24 $11,838 - $25,256	11,275 New	11,275 $12,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.